Pharma Mar SA
Clara Somoza Colino is a Senior Product Quality Manager at PharmaMar since May 2021, specializing in compliance with GMP/GDP regulations in the design, development, and production of APIs and drug products. Clara has prior experience as Quality Assurance Responsible at Normon Laboratories, where management of a team focused on quality investigations and corrective actions was key. Earlier roles include quality assurance positions at Boehringer Ingelheim - Merial and Sanofi, concentrating on external complaints and technical agreements with subcontractors. Clara began their career as a Jr. Research Associate at Eli Lilly and Company and has significant research experience from Universidad Complutense de Madrid and Universidad de Valladolid. Educational credentials include a Master of Science in Chemical Research from Queen Mary University of London and additional qualifications in Quality Management Systems from Universidad de Salamanca.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.